The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) recently issued a new clinical practice guideline for treating inhaled allergies with immunotherapy, aiming to provide physicians with trustworthy, evidence‐based recommendations.
Targeted immunotherapies have become part of ATC treatment over the last decade or so, boosting recognition of tumor cells and activation of the immune system. But the studies on their effects have been fairly scarce and heterogeneous.
Local nasal immunotherapy is a safe alternative immunotherapy route that improves clinical symptoms, reduces medication usage, and increases the nasal provocation threshold.
Otolaryngology practices these practices need to consider how best to re-engage their allergy immunotherapy patients, including answering: Which services to start with? Which patients? Which procedures?
Experts at the AAO-HNS Annual Meeting in Atlanta discuss checkpoint inhibitor success and ways to overcome resistance.
Research finds patients with seasonal allergies not well controlled by medication can be offered sublingual tablet immunotherapy
With the rising prevalence of food allergies and their associated potentially fatal consequences, understanding the pathophysiology of food allergies along with their diagnosis and treatment remains a critical part of otolaryngologic practice.
An expert panel containing three former American Academy of Otolaryngic Allergy presidents recently provided a look at the future of allergic rhinitis, as well as a refresher on how best to treat it.